Axillary Block in Association With Analgesic Truncal Blocks at the Elbow for Wrist Surgery.
NCT ID: NCT04046744
Last Updated: 2022-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2019-10-07
2022-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of this study is that, for the wrist surgery, axillary block using a short-acting LA combined with analgesic blocks at the elbow using a long-acting LA could provide a RA installation time reduction, an optimal surgical comfort, a longer post-operative analgesia duration and a faster recovery from motor block.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Clinical Trial Comparing Infraclavicular Versus Axillary Approach to Brachial Plexus Block
NCT02208245
Effect of Local Anaesthetic Volume on Axillary Brachial Plexus Block Duration
NCT03163472
Ultrasound-Guided Axillary or Infraclavicular Nerve Block for Upper Limb Surgery
NCT00724035
Ultrasound-guided Infraclavicular Block With Lidocaine or Ropivacaine for Closed Reduction of Distal Radius Fractures
NCT06379490
Descriptive Assessment of Practice in Anaesthesia : Lidocaine 1% Adrenaline Under in Axillary Block Realization
NCT03290404
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* BAX (usual technique) : Axillary brachial plexus block (Axillary block) with a long-acting LA (Ropivacaine)
* BAX-Asso (experimental technique) : Axillary brachial plexus block (Axillary block) with a short-acting local anesthetic (Lidocaine) + Analgesic block at the elbow with a long-acting local anesthetic (Ropivacaine) Every block will be performed under Ultrasound. BAX will be performed using a multi-injection technique at contact with median (nM), radial (nR), ulnar (nU), musculocutaneous (nMC) and medial antebrachial cutaneous (nCMAB) nerves. 15-30 mL of LA will be injected.
Analgesic truncal blocks of the median and radial nerves will be performed at the elbow. 3-7 mL of LA will be injected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BAX
Axillary brachial plexus block with a long-acting local anesthetic
axillary block with 15-30 ml Ropivacaine 0,5%.
Ropivacaine
axillary block with 15-30 ml Ropivacaine 0,5%
BAX-Asso
Axillary brachial plexus block with a short-acting local anesthetic + Analgesic block at the elbow with a long-acting local anesthetic
axillary block with 15-30 ml Lidocaine 1,5% + radial and medial nerve block at the elbow with 3-7 ml Ropivacaine 0,5%.
Ropivacaine
radial and medial nerve block at the elbow with 3-7 ml Ropivacaine 0,5%
Lidocaine
axillary block with 15-30 ml Lidocaine 1,5%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Axillary brachial plexus block with a long-acting local anesthetic
axillary block with 15-30 ml Ropivacaine 0,5%.
Axillary brachial plexus block with a short-acting local anesthetic + Analgesic block at the elbow with a long-acting local anesthetic
axillary block with 15-30 ml Lidocaine 1,5% + radial and medial nerve block at the elbow with 3-7 ml Ropivacaine 0,5%.
Ropivacaine
axillary block with 15-30 ml Ropivacaine 0,5%
Ropivacaine
radial and medial nerve block at the elbow with 3-7 ml Ropivacaine 0,5%
Lidocaine
axillary block with 15-30 ml Lidocaine 1,5%
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consent for participation
* Affiliation to the French social security system
Exclusion Criteria
* Chronic pain syndrome or fibromyalgia
* Contraindication for locoregional anesthesia
* Contraindication for opioid
* ASA IV
* Pregnant or breastfeeding women
* Patients under protection of the adults (guardianship, curators or safeguard of justice)
* Communication difficulties or neuropsychiatric disorder
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CMC Ambroise Paré
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique du Pré
Le Mans, Pays de la Loire Region, France
Hôpital Privé Paul D'Egine
Champigny-sur-Marne, Île-de-France Region, France
CMC Ambroise Paré
Neuilly-sur-Seine, Île-de-France Region, France
Hôpital Privé Armand Brillard
Nogent-sur-Marne, Île-de-France Region, France
Clinique Bizet
Paris, Île-de-France Region, France
Clinique Jouvenet
Paris, Île-de-France Region, France
Clinique Rémusat
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019/03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.